Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on February 27, 2008
J Am Soc Nephrol 19: 973-984, 2008
© 2008 American Society of Nephrology
doi: 10.1681/ASN.2007111166

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2007111166v1
19/5/973    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Nolan, S. L.
Right arrow Articles by Savage, C. O.S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nolan, S. L.
Right arrow Articles by Savage, C. O.S.
Related Collections
Right arrowRelated Article

BASIC RESEARCH

Mechanisms of ANCA-Mediated Leukocyte-Endothelial Cell Interactions In Vivo

Sarah L. Nolan*, Neena Kalia{dagger}, Gerard B. Nash{dagger}, Dia Kamel{ddagger}, Peter Heeringa§ and Caroline O.S. Savage*

* Renal Immunobiology, {dagger} Centre for Cardiovascular Sciences, and {ddagger} Department of Pathology, Medical School, University of Birmingham, Birmingham, United Kingdom; and § Department of Pathology and Laboratory Medicine, Medical Biology Section, University Medical Centre, Groningen, Netherlands

Correspondence: Prof. Caroline O.S. Savage, Renal Immunobiology, MRC Centre for Immune Regulation, The Medical School, University of Birmingham, Birmingham, B15 2TT, UK. Phone: +44-121-697-8427; Fax: +44-121-414-6794; E-mail: C.O.S.Savage{at}bham.ac.uk

Received for publication November 2, 2007. Accepted for publication January 3, 2008.

Anti-myeloperoxidase (anti-MPO) antibodies have been implicated in the pathogenesis of small-vessel vasculitis, but the molecular mechanisms by which these antibodies contribute to disease are unknown. For determination of how anti-MPO antibodies affect inflammatory cell recruitment in small-vessel vasculitis, intravital microscopy was used to monitor leukocyte behavior in the accessible cremasteric microvessels under various experimental conditions. After local pretreatment of the cremaster muscle with cytokines (TNF-{alpha}, IL-1β, or keratinocyte-derived chemokine), administration of anti-MPO IgG to wild-type mice reduced leukocyte rolling in favor of augmented adhesion to and transmigration across the endothelium. This led to a decrease in the number of systemic circulating leukocytes and, similar to the early events in the development of vasculitic lesions, an increase in leukocyte recruitment to renal and pulmonary tissue. TNF-{alpha} led to the greatest recruitment of inflammatory cells, and IL-1β led to the least. When anti-CD18 was co-administered, anti-MPO IgG did not affect leukocyte rolling, adhesion, or transmigration; similarly, anti-MPO IgG did not produce these effects in Fc receptor {gamma} chain–/– mice. This study provides direct in vivo evidence of enhanced leukocyte–endothelial cell interactions in the presence of anti-MPO IgG and highlights the critical roles of Fc{gamma} receptors and β2 integrins in mediating these interactions. In addition, it suggests that neutrophils primed by cytokines in the presence of anti-MPO IgG can have systemic effects and target specific vascular beds.


Related Article

This Month's Highlights
J. Am. Soc. Nephrol. 2008 19: A7. [Full Text] [PDF]






HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP